Analyst Ratings for Actinium Pharma (ATNM)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2024 | B.Riley | Yuan Zhi | Downgrade | Neutral (Buy) |
2.00 (N/A) |
2.87 (0.92) |
-67.94% | Details |
| 5/14/2024 | Stephens » Updated 11/19/2024 |
Sudan Loganathan | New Coverage | Overweight (N/A) |
5.00 (N/A) |
8.73 (0.92) |
-89.46% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
